A citation-based method for searching scientific literature

Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
Times Cited: 357



M Xing. Endocr Relat Cancer 2005
Times Cited: 878




List of shared articles



Times cited

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Meihua Jin, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon,[...]. Cancers (Basel) 2021
2


How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Marco Dell'Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz,[...]. Cancer Cytopathol 2021
0

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Yubing Tao, Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo,[...]. J Clin Endocrinol Metab 2021
0

Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.
Tomoe Nakao, Michiko Matsuse, Vladimir Saenko, Tatiana Rogounovitch, Aya Tanaka, Keiji Suzuki, Miyoko Higuchi, Hisanori Sasai, Tsutomu Sano, Mitsuyoshi Hirokawa,[...]. Clin Endocrinol (Oxf) 2021
0

Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population.
Marilena Argyropoulou, Aristidis S Veskoukis, Pagona-Maria Karanatsiou, Aikaterini Manolakelli, Ifigenia Kostoglou-Athanassiou, George Vilaras, Andreas Karameris, Kalliopi Liadaki. Pathol Oncol Res 2020
9

Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Chen Zheng, Er-Jie Xia, Rui-Da Quan, Adheesh Bhandari, Ou-Chen Wang, Ru-Tian Hao. Cell Biochem Funct 2020
3

Clinical and Translational Challenges in Thyroid Cancer.
Jorge Hernando, Javier Ros, Alvaro Arroyo, Jaume Capdevila. Curr Med Chem 2020
2


Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel.
Ali S Alzahrani, Meshael Alswailem, Anwar Ali Alswailem, Hindi Al-Hindi, Ewa Goljan, Nourah Alsudairy, Mohamed Abouelhoda. J Clin Endocrinol Metab 2020
7

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.
Dagmara Rusinek, Aleksandra Pfeifer, Marta Cieslicka, Malgorzata Kowalska, Agnieszka Pawlaczek, Jolanta Krajewska, Sylwia Szpak-Ulczok, Tomasz Tyszkiewicz, Monika Halczok, Agnieszka Czarniecka,[...]. Cancers (Basel) 2020
6

Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital.
Adhitya Bayu Perdana, Rizky Ifandriani Putri, Rachmawati Rachmawati, Bob Andinata, Bayu Brahma. Asian Pac J Cancer Prev 2020
1

Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Ali S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, Meshael M Alswailem, Balgees AlGhamdi, Yosra Moria, Hindi Al-Hindi. Endocrine 2019
7

Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and Outcome.
Ali S Alzahrani, Meshael Alswailem, Yosra Moria, Reem Almutairi, Metib Alotaibi, Avaniyapuram Kannan Murugan, Ebtesam Qasem, Balgees Alghamdi, Hindi Al-Hindi. J Clin Endocrinol Metab 2019
8

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
17